MedTrace Logo

Functional and Neurochemical Brain Changes Bipolar Depression

NCT00608296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2014-12-23

No results posted yet for this study

Summary

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.

Conditions

  • Depression, Bipolar

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Caleb M Adler, MD · University of Cincinnati

Eligibility

Min Age
12 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00608296 on ClinicalTrials.gov